ACI 17th Annual Paragraph IV Disputes Conference
New York, New York
BRG was a sponsor of the American Conference Institute (ACI) 17th Annual Paragraph IV Disputes Conference.
On April 26, Alyson Wooten joined Donna Meuth (Associate General Counsel, IP at Eisai Inc.), Bruce M. Wexler (Partner and Global Co-Chair, Intellectual Property at Paul Hastings LLP), Richard J. Berman (Partner at ArentFox Schiff LLP), and Jovial Wong (Partner at Winston & Strawn LLP) to discuss “The Practice of Paragraph IV Disputes – Mastering the Use of Experts in Parallel Proceedings.”
This track covered the following:
- Developing strategies to use expert testimony at both the district court and Patent Trial and Appeal Board (PTAB) in a dual-proceedings scenario
- Understanding the scope and limitations of expert testimony at the PTAB and how this may impact the district court proceeding
- Appreciating the nuances of expert depositions for PTAB and district court proceedings
- Ensuring that your expert communicates properly for the requisite forum
About the Conference
Each year, leading pharmaceutical patent litigators for brand name and generic drug companies along with representatives from key government agencies and the Federal Judiciary gather at ACI’s Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation. As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape as well as the impact of the global pandemic, the time for this conference has never been more relevant.